"Ln(TePh)(3)" (Ln = Er, Tm, Lu), prepared in situ by the reduction of PhTeTePh with elemental Ln in the presence of Hg catalyst, reacts with elemental Te to give heterometallic clusters with the formula (py)(7)Ln(3)HgTe(4)(TePh)(3). Structural characterization of all three isostructural derivatives reveals a cubane arrangement of metal ions, with a distorted tetrahedral Hg(II) ion coordinated to three mu(3) coordinate Te(2-) and a terminal TePh ligand. There are two chemically inequivalent types of octahedral Ln(III) ions, one bound to three Te(2-) and three pyridine donors, and two that coordinate two pyridine, three Te(2-), and a terminal TePh ligand. The Lu compound decomposes at elevated temperatures to give LuTe.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/ic9021189 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Loss of Estradiol by Androgen Deprivation in Prostate Cancer Patients Shows the Importance of Estrogens in Males.
J Endocr Soc
May 2024
Division of Urology, University Clinic Saint-Luc, 1200 Brussels, Belgium.
The role of estradiol (E2; an estrogen) in men needs to be more appreciated. In this review, we address the clinical situations that allow the study of the clinical consequences of E2 deficiency in men and discuss the effects of restoration of levels of this reproductive steroid hormone. In men with advanced prostate cancer (PCa) undergoing androgen deprivation therapy (ADT), E2 is suppressed along with testosterone, leading to side effects affecting the quality of life.
View Article and Find Full Text PDFMaintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative review.
Endocr Connect
December 2022
Andros Clinics, Arnhem, The Netherlands.
The purpose of androgen deprivation therapy (ADT) in prostate cancer (PCa), using luteinizing hormone-releasing hormone agonists (LHRHa) or gonadotrophin-releasing hormone antagonists, is to suppress the levels of testosterone. Since testosterone is the precursor of estradiol (E2), one of the major undesired effects of ADT is the concomitant loss of E2, causing among others an increased bone turnover and bone loss and an increased risk of osteoporosis and fractures. Therefore, the guidelines for ADT indicate to combine ADT routinely with bone-sparing agents such as bisphosphonates, denosumab or selective estrogen receptor modulators.
View Article and Find Full Text PDF[Hierarchical structure of Five-shu points and Source-point of Triple Energizer Meridian in rabbits].
Zhen Ci Yan Jiu
July 2020
Faculty of Health Sciences, University of Macau, Macau SAR 999078, China.
Objective: To study the position and hierarchical structure of Five-shu points, i．e., "Guanchong" (TE1), "Yemen" (TE2), "Zhongzhu" (TE3), "Yangchi" (TE4) and "Zhigou" (TE6), and the Source-point "Tianjing" (TE10) of the Triple Energizer (TE) Meridian in the rabbit.
Methods: Based on WHO Standard Acupuncture Point Locations in the Western Pacific Region (WHO Standard) and National Standard (GB/T 22103-2008) for Acupuncture Point Locations in human body, and combined with X-ray images, the hierarchical structure of Five-shu points and Source-point of the TE Meridian were observed in ten New Zealand rabbits.
Covalent surface modifications and superconductivity of two-dimensional metal carbide MXenes.
Science
August 2020
Department of Chemistry and James Franck Institute, University of Chicago, Chicago, IL 60637, USA.
Versatile chemical transformations of surface functional groups in two-dimensional transition-metal carbides (MXenes) open up a previously unexplored design space for this broad class of functional materials. We introduce a general strategy to install and remove surface groups by performing substitution and elimination reactions in molten inorganic salts. Successful synthesis of MXenes with oxygen, imido, sulfur, chlorine, selenium, bromine, and tellurium surface terminations, as well as bare MXenes (no surface termination), was demonstrated.
View Article and Find Full Text PDFThe Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?
Menopause
September 2019
Phoenix Veterans Administration Health Care System, Phoenix, AZ.
Objective: The Kronos Early Estrogen Prevention Study (KEEPS) was designed to address gaps in understanding the effects of timely menopausal hormone treatments (HT) on cardiovascular health and other effects of menopause after the premature termination of the Women's Health Initiative.
Method: The KEEPS was a randomized, double-blinded, placebo-controlled trial to test the hypothesis that initiation of HT (oral conjugated equine estrogens [o-CEE] or transdermal 17β-estradiol [t-E2]) in healthy, recently postmenopausal women (n = 727) would slow the progression of atherosclerosis as measured by changes in carotid artery intima-media thickness (CIMT).
Results: After 4 years, neither HT affected the rate of increase in CIMT.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!